Skip to content

Join us at this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

Development of highly-differentiated human primary proximal tubule MPS model

The proximal tubule (PT) is the key nephron segment mediating renal drug elimination and is the primary site of drug induced nephrotoxicity.

However, current animal studies have proved poorly predictive of human outcome. To address this, there has been a recent upsurge in physiological relevant microphysiological systems (MPS) of PT to recapitulate differentiation and function in vitro. Here we present results from our recently developed aProximate MPS™ human PT platform (Patent No: G001336.GB), in which primary human PT cells are subject to fluidic media flow and a shear stress between 0.1-2 dynes/cm².

Find out more about our aProximate™ PT model here


19th January, 2023

Published by

Donovan O’Brien, Francesca Pisapia, Elena Tasinato, Kathryn Garner and Colin Brown

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download Now

Get our latest updates straight to your inbox